Analysis of protein binding sites by computational solvent mapping.

Computational solvent mapping globally samples the surface of target proteins using molecular probes-small molecules or functional groups-to identify potentially favorable binding positions. The method is based on X-ray and NMR screening studies showing that the binding sites of proteins also bind a large variety of fragment-sized molecules. We have developed the multistage mapping algorithm FTMap (available as a server at http://ftmap.bu.edu/ ) based on the fast Fourier transform (FFT) correlation approach. Identifying regions of low free energy rather than individual low energy conformations, FTMap reproduces the available experimental mapping results. Applications to a variety of proteins show that the probes always cluster in important subsites of the binding site, and the amino acid residues that interact with many probes also bind the specific ligands of the protein. The "consensus" sites at which a number of different probes cluster are likely to be "druggable" sites, capable of binding drug-size ligands with high affinity. Due to its sensitivity to conformational changes, the method can also be used for comparing the binding sites in different structures of a protein.

[1]  T. Clackson,et al.  A hot spot of binding energy in a hormone-receptor interface , 1995, Science.

[2]  Dima Kozakov,et al.  Detection of ligand binding hot spots on protein surfaces via fragment-based methods: application to DJ-1 and glucocerebrosidase , 2009, J. Comput. Aided Mol. Des..

[3]  Sandor Vajda,et al.  Characterization of protein-ligand interaction sites using experimental and computational methods. , 2006, Current opinion in drug discovery & development.

[4]  Karl H. Clodfelter,et al.  Identification of substrate binding sites in enzymes by computational solvent mapping. , 2003, Journal of molecular biology.

[5]  P. Hajduk,et al.  Predicting protein druggability. , 2005, Drug discovery today.

[6]  R E Hubbard,et al.  Experimental and computational mapping of the binding surface of a crystalline protein. , 2001, Protein engineering.

[7]  Dima Kozakov,et al.  The structural basis of pregnane X receptor binding promiscuity. , 2009, Biochemistry.

[8]  Karen N. Allen,et al.  An Experimental Approach to Mapping the Binding Surfaces of Crystalline Proteins , 1996 .

[9]  G. Petsko,et al.  Multiple solvent crystal structures: probing binding sites, plasticity and hydration. , 2006, Journal of molecular biology.

[10]  P. Hajduk,et al.  Druggability indices for protein targets derived from NMR-based screening data. , 2005, Journal of medicinal chemistry.

[11]  Gianni Chessari,et al.  Application of fragment screening by X-ray crystallography to the discovery of aminopyridines as inhibitors of beta-secretase. , 2007, Journal of medicinal chemistry.

[12]  Dima Kozakov,et al.  Fragment-based identification of druggable 'hot spots' of proteins using Fourier domain correlation techniques , 2009, Bioinform..

[13]  D. Ringe,et al.  Locating and characterizing binding sites on proteins , 1996, Nature Biotechnology.

[14]  Sandor Vajda,et al.  Identification of hot spots within druggable binding regions by computational solvent mapping of proteins. , 2007, Journal of medicinal chemistry.

[15]  Dima Kozakov,et al.  Binding hot spots and amantadine orientation in the influenza a virus M2 proton channel. , 2009, Biophysical journal.

[16]  Gianni Chessari,et al.  Application of fragment screening by X-ray crystallography to beta-secretase. , 2007, Journal of medicinal chemistry.

[17]  R E Hubbard,et al.  Locating interaction sites on proteins: The crystal structure of thermolysin soaked in 2% to 100% isopropanol , 1999, Proteins.

[18]  Sandor Vajda,et al.  Computational mapping identifies the binding sites of organic solvents on proteins , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[19]  David Ozonoff,et al.  Novel Druggable Hot Spots in Avian Influenza Neuraminidase H5N1 Revealed by Computational Solvent Mapping of a Reduced and Representative Receptor Ensemble , 2008, Chemical biology & drug design.